Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Young women with PCOS and no other heart risk factors have normal heart function.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Some sports supplements can cause health issues like mood swings, hair loss, and heart problems in men.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Acarbose may improve PCOS symptoms and fertility, but more research is needed.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Androgen use may increase the risk of stroke, but more research is needed.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.